UPDATED Apr 01, 2024
Financially strong companies with expected earnings growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
INCY | US$56.64 | -1.5% | -22.0% | US$12.8b | US$76.01 | PE21.3x | E20.1% | n/a | ||
NBIX | US$141.38 | 0.8% | 40.2% | US$13.7b | US$151.79 | PE56.3x | E26.5% | n/a | ||
CORT | US$25.74 | 4.4% | 14.3% | US$2.6b | US$42.80 | PE25.3x | E26.2% | n/a | ||
EXEL | US$23.68 | -0.08% | 21.6% | US$7.2b | US$26.63 | PE34.6x | E23.3% | n/a | ||
HRMY | US$33.01 | 1.3% | -0.5% | US$1.9b | US$41.63 | PE14.5x | E25.8% | n/a | ||
BMRN | US$87.10 | 0.7% | -9.8% | US$16.5b | US$109.83 | PE98x | E30.7% | n/a | ||
PCRX | US$29.15 | -0.3% | -29.5% | US$1.4b | US$45.73 | PE32.3x | E29.3% | n/a | ||
ANIP | US$67.87 | -2.5% | 74.8% | US$1.4b | US$79.80 | PE86.5x | E37.4% | n/a | ||
VRTX | US$420.48 | 1.1% | 32.9% | US$108.0b | US$459.71 | PE30x | E11.2% | n/a | ||
PNT | US$12.50 | 0.2% | 75.1% | US$1.3b | US$12.50 | PE13.8x | E9.2% | n/a | ||
MDXG | US$7.45 | -4.9% | 123.1% | US$1.1b | US$12.44 | PE19.6x | E15.0% | n/a |